7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Nautilus Biotechnology Inc
(NASDAQ:NAUT) 

NAUT stock logo

Founded: 2016
CEO: Sujal Patel  
Sector:
Industry:

Share this website to your friends
Nautilus Biotechnology Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 020.8141.6362.4483.26104.07124.88145.7
Nautilus Biotechnology Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.47-0.4-0.33-0.27-0.2-0.13-0.07-0
Nautilus Biotechnology Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.5-0.43-0.35-0.28-0.21-0.14-0.070
Nautilus Biotechnology Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.340.691.031.371.722.062.4
Nautilus Biotechnology (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -5,611.74-4,810.06-4,008.38-3,206.71-2,405.03-1,603.35-801.680
Nautilus Biotechnology P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0183.02366.04549.07732.09915.111,098.131,281.16
No extra charts and metrics for this ticker.